Amlodipine And Valsartan
Product Images NDC 45865-890

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (890)

Amlodipine and valsartan tablets 5 mg/320 mg by medsource pharmaceuticals. The label indicates the product is generic for Exforge, contains 100 tablets, and is from Aurobindo Pharma Ltd. Directions note not to use if pregnant and to take tablets as directed by a physician. The packaging is primarily white with green text and a green border.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)

A line graph depicting the probability of achieving systolic blood pressure below 140 mmHg at Week 8 versus baseline systolic blood pressure in mmHg. Four groups are compared: Amlodipine and Valsartan Tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo, each represented by distinct markers and lines as indicated in the legend.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlo Val Fig2)

A line graph showing the probability of achieving diastolic blood pressure below 90 mmHg at week 8, plotted against baseline diastolic blood pressure (DBP) in mmHg. Four curves represent Amlodipine and Valsartan Tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo, with the combined tablets showing the highest probabilities across the baseline DBP range.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlo Val Fig3)

A line graph showing the probability of achieving systolic blood pressure below 130 mmHg at week 8, comparing different treatments: amlodipine and valsartan tablets 10 mg/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo. The X-axis represents baseline systolic blood pressure in mmHg, and the Y-axis shows the percentage achieving target blood pressure.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlo Val Fig4)

A line graph showing the probability of achieving diastolic blood pressure below 80 mmHg at week 8. The x-axis represents baseline diastolic blood pressure in mmHg from 95 to 110, while the y-axis shows the percentage achieving this target from 0 to 100%. Four lines compare Amlodipine and Valsartan tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo.*

FDA Label Image

Chemical Structure1 (Amlo Val Str1)

Chemical structure of the active ingredient for Amlodipine and valsartan, showing molecular components with labels for functional groups including chlorine (Cl), ester groups, and sulfonic acid (SO3H) attached to aromatic rings.*

FDA Label Image

Chemical Structure2 (Amlo Val Str2)

Chemical structure diagram of valsartan, part of the active ingredients in Amlodipine and valsartan by medsource pharmaceuticals, NDC 45865-890. The structure illustrates the molecular arrangement of atoms in valsartan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.